Clinical Trial: Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: A COMPARASON OF CIDECIN™ (DAPTOMYCIN) TO ROCEPHIN® (CEFTRIAXONE) IN THE TREATMENT OF MODERATE TO SEVERE COMMUNITY-ACQUIRED ACUTE BACTERIAL PNEUMONIA DUE TO S. PNEUMONIAE
Detailed Summary:
Sponsor: Cubist Pharmaceuticals LLC
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Cubist Pharmaceuticals LLC
Dates:
Date Received: October 4, 2007
Date Started: July 2001
Date Completion:
Last Updated: July 16, 2015
Last Verified: October 2007